94 related articles for article (PubMed ID: 18607998)
21. [A case report of S-1 monotherapy as first-line treatment for metastatic gallbladder cancer].
Amano A; Ohkawa S; Ueno M
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1307-9. PubMed ID: 17687220
[TBL] [Abstract][Full Text] [Related]
22. Preclinical analysis of the antitumor efficacy of TS-1 using human uterine cervical cancer tumor xenografts.
Nagai N; Komatsu M; Yunokawa M; Shiroyama Y; Hirata E
Oncol Rep; 2008 Nov; 20(5):1149-56. PubMed ID: 18949415
[TBL] [Abstract][Full Text] [Related]
23. The optimal schedule for 5-fluorouracil radiosensitization in colon cancer cell lines.
Ojima E; Inoue Y; Watanabe H; Hiro J; Toiyama Y; Miki C; Kusunoki M
Oncol Rep; 2006 Nov; 16(5):1085-91. PubMed ID: 17016597
[TBL] [Abstract][Full Text] [Related]
24. Oncolytic gene therapy combined with double suicide genes for human bile duct cancer in nude mouse models.
Kojima Y; Honda K; Hamada H; Kobayashi N
J Surg Res; 2009 Nov; 157(1):e63-70. PubMed ID: 19345377
[TBL] [Abstract][Full Text] [Related]
25. Effect of gastrectomy on the pharmacokinetics of S-1, an oral fluoropyrimidine, in resectable gastric cancer patients.
Kochi M; Fujii M; Kanamori N; Kaiga T; Aizaki K; Takahashi T; Takayama T
Cancer Chemother Pharmacol; 2007 Oct; 60(5):693-701. PubMed ID: 17690883
[TBL] [Abstract][Full Text] [Related]
26. [Safe and successful chemoradiotherapy for a patient with cardiac pacemaker and triple cancers].
Kikuchi D; Iizuka T; Hoteya S; Miyata Y; Mitani T; Ochiai Y; Sakurada T; Hirano N; Hayashi T; Nakamura M; Yahagi N
Gan To Kagaku Ryoho; 2009 Jun; 36(6):1025-7. PubMed ID: 19542730
[TBL] [Abstract][Full Text] [Related]
27. [Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil].
Yamada Y
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():37-41. PubMed ID: 16897970
[TBL] [Abstract][Full Text] [Related]
28. TS-1 enhances the effect of radiotherapy by suppressing radiation-induced hypoxia-inducible factor-1 activation and inducing endothelial cell apoptosis.
Zeng L; Ou G; Itasaka S; Harada H; Xie X; Shibuya K; Kizaka-Kondoh S; Morinibu A; Shinomiya K; Hiraoka M
Cancer Sci; 2008 Nov; 99(11):2327-35. PubMed ID: 18823375
[TBL] [Abstract][Full Text] [Related]
29. [Two cases of head and neck squamous cell carcinoma in which S-1 administration resulted in long-term sustained QOL].
Shimane T; Mori T; Ono T; Monden T; Furuya A; Kobayashi S; Sanbe T; Suzaki H
Gan To Kagaku Ryoho; 2009 Jul; 36(7):1141-4. PubMed ID: 19620804
[TBL] [Abstract][Full Text] [Related]
30. [Effect of delayed-release 5-fluorouracil implants on colorectal cancer].
Wang N; Chen L; Wei B; Wang BS; Li JQ; Zheng W
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Jan; 13(1):57-9. PubMed ID: 20099164
[TBL] [Abstract][Full Text] [Related]
31. Antitumor effect of combination of S-1 and docetaxel on the human breast cancer xenograft transplanted into SCID mice.
Suto A; Kubota T; Fukushima M; Ikeda T; Takeshita T; Ohmiya H; Kitajima M
Oncol Rep; 2006 Jun; 15(6):1517-22. PubMed ID: 16685389
[TBL] [Abstract][Full Text] [Related]
32. [Effects of anti-gene and antisense therapeutics on human prostate cancer xenograft in nude mice].
Zhang Y; Ma Y; Lu HP; Zhou XF; Xie Y; Gao JH; Liang CS
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2073-6. PubMed ID: 19080439
[TBL] [Abstract][Full Text] [Related]
33. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
[TBL] [Abstract][Full Text] [Related]
34. [Severe advanced lower gingival carcinoma effectively reduced by chemoradiation with S-1--report of a case].
Ishibashi M; Masuda N; Noguchi K; Moridera K; Nishimura N; Takayama T; Nishioji K; Urade M; Kogo M
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1837-9. PubMed ID: 18030019
[TBL] [Abstract][Full Text] [Related]
35. Advantage of combining NLCQ-1 (NSC 709257) with radiation in treatment of human head and neck xenografts.
Papadopoulou MV; Bloomer WD; Taylor AP; Hernandez M; Blumenthal RD; Hollingshead MG
Radiat Res; 2007 Jul; 168(1):65-71. PubMed ID: 17722994
[TBL] [Abstract][Full Text] [Related]
36. Diamine oxidase, a plasma biomarker in rats to GI tract toxicity of oral fluorouracil anti-cancer drugs.
Moriyama K; Kouchi Y; Morinaga H; Irimura K; Hayashi T; Ohuchida A; Goto T; Yoshizawa Y
Toxicology; 2006 Jan; 217(2-3):233-9. PubMed ID: 16278042
[TBL] [Abstract][Full Text] [Related]
37. [A case of effective chemoradiotherapy using S-1 and CDDP for left inguinal lymph node metastasis of anal canal carcinoma].
Kuga Y; Tanaka T; Arita M; Usui Y; Okanobu H; Numata Y; Miwata T; Yoshimi S; Murakami E; Moriya T; Ohya T; Nishida T
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1923-5. PubMed ID: 19920402
[TBL] [Abstract][Full Text] [Related]
38. [Concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma].
Ikeda Y; Tsukuda M; Tanigaki Y; Yabuki K; Mitake D; Ishitoya J
Gan To Kagaku Ryoho; 2008 May; 35(5):789-92. PubMed ID: 18487914
[TBL] [Abstract][Full Text] [Related]
39. A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancer.
Chikamori K; Kishino D; Takigawa N; Hotta K; Nogami N; Kamei H; Kuyama S; Gemba K; Takemoto M; Kanazawa S; Ueoka H; Segawa Y; Takata S; Tabata M; Kiura K; Tanimoto M;
Lung Cancer; 2009 Jul; 65(1):74-9. PubMed ID: 19056143
[TBL] [Abstract][Full Text] [Related]
40. Pre-exposure to Fluorouracil Increased Trifluridine Incorporation and Enhanced its Anti-tumor Effect for Colorectal Cancer.
Baba T; Kokuryo T; Yamaguchi J; Yokoyama Y; Uehara K; Ebata T; Nagino M
Anticancer Res; 2018 Mar; 38(3):1427-1434. PubMed ID: 29491068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
